ClinicalTrials.gov
public full text
Public Domain
Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease
In this first study of inhaled apomorphine in Parkinson's disease patients, the primary objective is to find the minimum efficacious dose of apomorphine that is useful in rescuing patients during 'off' periods. Safety, tolerability and pharmacokinetics of inhaled apomorphine will be assessed during the study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric#902990
- Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study#378000
- Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease#1033185
- A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients#911944
- Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease#1171377
Record · ID 980112
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive